Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Goal-Directed Fluid Therapy During Esophageal Resection
2011-000254-39Phase 4Completed
- Sponsor
- Anestesi och Operationskliniken
- Start
- Jul 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dobutamine, phenylephrine, norepinephrine and albumin (human) in esophageal cancer (2 arms), sponsored by Anestesi och Operationskliniken. Primary endpoint: Postoperative complications. Started Jul 2011; status: completed.
02
Drugs
dobutaminephenylephrinenorepinephrinealbumin (human)
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on 2011-000254-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000254-39.